Pause med trombocytaggregationshaemmere hos kirurgiske patienter med kardiel stent

Mathias Johansen; Arash Afshari; Billy Kristensen

Pause med trombocytaggregationshaemmere hos kirurgiske patienter med kardiel stent

Translated title of the contribution: [Discontinuation of treatment with platelet aggregation inhibitors in surgical patients with cardiac stents]

Mathias Johansen, Arash Afshari, Billy Kristensen

Department of Clinical Medicine

2 Citations (Scopus)

Abstract

Dual antiplatelet therapy with aspirin and clopidogrel is increasingly used for secondary prevention of cardiovascular events in patients with percutaneous coronary intervention. Anesthesiologists and surgeons are faced with the challenge of managing these patients prior to a surgical procedure. Premature discontinuation of antiplatelet therapy constitutes a substantial risk of stent thrombosis, myocardial infarction and death. Continuing therapy increases the risk of bleeding. We provide the latest evidence on this topic for patients awaiting non-cardiac surgery.

Translated title of the contribution	[Discontinuation of treatment with platelet aggregation inhibitors in surgical patients with cardiac stents]
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	172
Issue number	11
Pages (from-to)	852-7
Number of pages	6
ISSN	0041-5782
Publication status	Published - 15 Mar 2010

Cite this

@article{ae8ea082bfbf4ab1868e0ececd474ce6,

title = "Pause med trombocytaggregationshaemmere hos kirurgiske patienter med kardiel stent",

abstract = "Dual antiplatelet therapy with aspirin and clopidogrel is increasingly used for secondary prevention of cardiovascular events in patients with percutaneous coronary intervention. Anesthesiologists and surgeons are faced with the challenge of managing these patients prior to a surgical procedure. Premature discontinuation of antiplatelet therapy constitutes a substantial risk of stent thrombosis, myocardial infarction and death. Continuing therapy increases the risk of bleeding. We provide the latest evidence on this topic for patients awaiting non-cardiac surgery.",

author = "Mathias Johansen and Arash Afshari and Billy Kristensen",

year = "2010",

month = mar,

day = "15",

language = "Dansk",

volume = "172",

pages = "852--7",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "11",

}

TY - JOUR

T1 - Pause med trombocytaggregationshaemmere hos kirurgiske patienter med kardiel stent

AU - Johansen, Mathias

AU - Afshari, Arash

AU - Kristensen, Billy

PY - 2010/3/15

Y1 - 2010/3/15

N2 - Dual antiplatelet therapy with aspirin and clopidogrel is increasingly used for secondary prevention of cardiovascular events in patients with percutaneous coronary intervention. Anesthesiologists and surgeons are faced with the challenge of managing these patients prior to a surgical procedure. Premature discontinuation of antiplatelet therapy constitutes a substantial risk of stent thrombosis, myocardial infarction and death. Continuing therapy increases the risk of bleeding. We provide the latest evidence on this topic for patients awaiting non-cardiac surgery.

AB - Dual antiplatelet therapy with aspirin and clopidogrel is increasingly used for secondary prevention of cardiovascular events in patients with percutaneous coronary intervention. Anesthesiologists and surgeons are faced with the challenge of managing these patients prior to a surgical procedure. Premature discontinuation of antiplatelet therapy constitutes a substantial risk of stent thrombosis, myocardial infarction and death. Continuing therapy increases the risk of bleeding. We provide the latest evidence on this topic for patients awaiting non-cardiac surgery.

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 172

SP - 852

EP - 857

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 11

ER -

Pause med trombocytaggregationshaemmere hos kirurgiske patienter med kardiel stent

Abstract

Fingerprint

Cite this